PODD vs RNST · P/E 34, rev $2.07B vs P/E 17, $3.80B cap
Insulet Corporation (PODD) versus Renasant Corporation (RNST) — a side-by-side from cached financials, not a winner call.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
Renasant Corporation (RNST) is a banks - regional company listed on NYSE.
Latest reported PODD revenue for 2024-12-31 was $2.07B. Net income was $418.3M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
RNST does not have a complete income-statement cache yet.
PODD currently screens at market cap $9.94B and trailing P/E 33.5. RNST currently screens at market cap $3.80B and trailing P/E 17.5.
Not investment advice. Open the PODD and RNST stock pages for the full models.
Not investment advice.